{"url_path":"/fda/drug/recalls/D-0774-2026","section_key":"summary","section_title":"DRUG Recall: Mylan Pharmaceuticals Inc — Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-24","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0774-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Mylan Pharmaceuticals Inc"},"word_count":68,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0774-2026\n\n**Recalling firm:** Mylan Pharmaceuticals Inc\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-24\n**Report date:** 2026-08-26\n\n## Product\nAcamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles, Rx only, Mylan Pharmaceuticals Inc., Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 266505, NDC 0378-6333-80.\n\n## Reason\nFailed Dissolution Specifications\n\n## Affected lots\nLot# 3227809; Expiry:10/2026; NDC #: 0378-6333-80\n\n## Distribution\nUS Nationwide."}